DIMENSIONAL FUND ADVISORS LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$107,148
-48.3%
74,408
-10.6%
0.00%
Q2 2023$207,295
-13.2%
83,251
-6.6%
0.00%
Q1 2023$238,878
+11849.9%
89,133
-75.8%
0.00%
-100.0%
Q4 2022$1,999
-100.0%
367,969
-21.1%
0.00%
-50.0%
Q3 2022$5,825,000
+119.2%
466,430
-13.3%
0.00%
+100.0%
Q2 2022$2,657,000
-38.2%
537,987
-5.0%
0.00%0.0%
Q1 2022$4,302,000
-19.7%
566,011
+7.9%
0.00%
-50.0%
Q4 2021$5,358,000
-32.3%
524,733
-11.0%
0.00%
-33.3%
Q3 2021$7,911,000
-66.3%
589,331
-44.9%
0.00%
-57.1%
Q2 2021$23,480,000
+15.3%
1,070,124
+26.6%
0.01%0.0%
Q1 2021$20,373,000
+90.8%
845,067
+42.4%
0.01%
+75.0%
Q4 2020$10,677,000
+55.5%
593,454
-0.2%
0.00%
+33.3%
Q3 2020$6,867,000
-51.2%
594,507
+2.5%
0.00%
-50.0%
Q2 2020$14,076,000
+136.0%
580,210
+7.2%
0.01%
+100.0%
Q1 2020$5,965,000
-57.5%
541,225
+1.8%
0.00%
-40.0%
Q4 2019$14,045,000
+60.3%
531,414
+38.3%
0.01%
+66.7%
Q3 2019$8,761,000
-12.7%
384,174
+17.3%
0.00%
-25.0%
Q2 2019$10,039,000
+146.9%
327,419
+33.7%
0.00%
+100.0%
Q1 2019$4,066,000
+159.0%
244,959
+198.8%
0.00%
+100.0%
Q4 2018$1,570,00081,9700.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 98,482$1,631,0000.60%
Opus Point Partners Management, LLC 20,844$346,0000.47%
HHLR ADVISORS, LTD. 949,431$15,761,0000.44%
Rhenman & Partners Asset Management AB 212,169$3,522,0000.41%
Virtus ETF Advisers LLC 8,654$144,0000.31%
BB BIOTECH AG 671,925$11,154,0000.28%
RA Capital Management 363,051$6,027,0000.26%
BDO Wealth Advisors, LLC 35,234$585,0000.17%
Birchview Capital, LP 15,000$249,0000.16%
SECOR Capital Advisors, LP 37,205$618,0000.13%
View complete list of G1 THERAPEUTICS INC shareholders